Clinical Characteristics of Hospitalized Patients With COVID‐19 and Their Association With the Progression to Critical Illness and Death: A Single‐Center Retrospective Study From Northwestern Mexico
Francisco A. Martínez‐Villa, Uriel A. Angulo‐Zamudio, Nidia Leon‐Sicairos, Ricardo González‐Esparza, Jaime Sanchez‐Cuen, Jesus J. Martinez‐Garcia, Hector Flores‐Villaseñor, Julio Medina‐Serrano, Adrian Canizalez‐Roman

TL;DR
This study identifies factors like age, health conditions, and lab results linked to severe illness and death in hospitalized COVID-19 patients in northwestern Mexico.
Contribution
The study identifies specific clinical and epidemiological markers associated with critical illness and death from COVID-19 in a regional Mexican population.
Findings
Advanced age, underlying diseases, and previous hospital treatment were linked to critical illness and death.
Clinical parameters like heart rate, respiratory rate, and lab values (e.g., glucose, creatinine) were associated with critical illness.
No symptoms were directly associated with critical illness, but several lab and vital signs were significant.
Abstract
The objective of this study was to associate the epidemiological and clinical characteristics of patients hospitalized for COVID‐19 with the progression to critical illness and death in northwestern Mexico. From March to October 2020, we collected the demographic and clinical characteristics of 464 hospitalized patients from northwestern Mexico. Sixty‐four percent (295/464) of the patients became critically ill. Age, occupation, steroid and antibiotic use at previous hospitalization, and underlying diseases (hypertension, obesity, and chronic kidney disease) were associated with critical illness or death (p: < 0.05). No symptoms were associated with critical illness. However, the parameters such as the heart rate, respiratory rate, oxygen saturation, and diastolic pressure and the laboratory parameters such as the glucose, creatinine, white line cells, hemoglobin, D‐dimer, and…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 Clinical Research Studies · Long-Term Effects of COVID-19 · Intensive Care Unit Cognitive Disorders
